Company Name: ADVAITE Inc.
Company Size: <50 Employees
What’s your mission?
The word ‘Advaite’ means ‘one without a second’, unrivaled or unique. At ADVAITE, we aspire to develop novel therapeutics and diagnostics to help patients suffering from a variety of debilitating diseases, primarily within the oncology space. During the deadly COVID-19 pandemic, ADVAITE expanded our mission to include developing novel point-of-care assays to help combat the pandemic and opened high-complexity CLIA Certified Laboratories in Chicago, IL and Malvern, PA to improve access to COVID-19 testing.
What do you do?
ADVAITE Inc. has two primary lines of business:
1) Development of novel therapeutic and diagnostic products: ADVAITE’s initial developed the RapCOV Rapid COVID-19 Test for qualitative presumptive detection of IgM and IgG antibodies to SARS-COV-2 in human whole blood.
2) Clinical Laboratory Services (COVID-19 Testing) SalivaDirect- Is a non-invasive saliva-based COVID-19 RT-PCR Test intended for detecting active COVID-19 infection.
Nasal Swab RT-PCR COVID-19 Test- For situations requiring the Nasal Swab RT-PCR Tests, ADVAITE offers these tests as well.
COVID-19 Antibody Testing- This is a highly specialized Antibody Test. This test is used for the qualitative detection of IgG antibodies to SARS-CoV-2 in human serum or plasma. Due to workflow constraints, appointments must be scheduled at least 24Hrs prior to sample collection.
What is the story behind your company and what are you known for?
ADVAITE Inc. is a Malvern, PA headquartered biotech company.
The ADVAITE RapCov™ Rapid COVID-19 Test is a lateral flow immunochromatographic assay for qualitative detection of IgG antibodies to SARS-CoV-2 in human finger-stick whole blood specimens. RapCOV has been authorized for emergency use by FDA under an Emergency Use Authorization (EUA).